BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Najafi M, Goradel NH, Farhood B, Salehi E, Solhjoo S, Toolee H, Kharazinejad E, Mortezaee K. Tumor microenvironment: Interactions and therapy. J Cell Physiol. 2019;234:5700-5721. [PMID: 30378106 DOI: 10.1002/jcp.27425] [Cited by in Crossref: 71] [Cited by in F6Publishing: 95] [Article Influence: 17.8] [Reference Citation Analysis]
Number Citing Articles
1 Yang Y, Ge J, Li G, Lei H, Chen L, Gong Y, Zhong X, Wang L, Dai Y, Tang W, Zou J, Cheng Y, Liu Z, Cheng L. Manganese-doping titanium disulfide cascade nanobioreactors for sequential gas-sonodynamic strategy with immune checkpoint blockade therapy of cancer. Nano Today 2022;46:101585. [DOI: 10.1016/j.nantod.2022.101585] [Reference Citation Analysis]
2 Bai R, Li Y, Jian L, Yang Y, Zhao L, Wei M. The hypoxia-driven crosstalk between tumor and tumor-associated macrophages: mechanisms and clinical treatment strategies. Mol Cancer 2022;21:177. [PMID: 36071472 DOI: 10.1186/s12943-022-01645-2] [Reference Citation Analysis]
3 Sencha LM, Dobrynina OE, Pospelov AD, Guryev EL, Peskova NN, Brilkina AA, Cherkasova EI, Balalaeva IV. Real-Time Fluorescence Visualization and Quantitation of Cell Growth and Death in Response to Treatment in 3D Collagen-Based Tumor Model. IJMS 2022;23:8837. [DOI: 10.3390/ijms23168837] [Reference Citation Analysis]
4 Qi S, Deng S, Lian Z, Yu K. Novel Drugs with High Efficacy against Tumor Angiogenesis. IJMS 2022;23:6934. [DOI: 10.3390/ijms23136934] [Reference Citation Analysis]
5 Agostini A, Orlacchio A, Carbone C, Guerriero I. Understanding Tricky Cellular and Molecular Interactions in Pancreatic Tumor Microenvironment: New Food for Thought. Front Immunol 2022;13:876291. [DOI: 10.3389/fimmu.2022.876291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Vitale M, Scialò F, Passariello M, Leggiero E, D’agostino A, Tripodi L, Gentile L, Bianco A, Castaldo G, Cerullo V, De Lorenzo C, Pastore L. Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model. Front Oncol 2022;12:902190. [DOI: 10.3389/fonc.2022.902190] [Reference Citation Analysis]
7 Yang R, Yi M, Xiang B. Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer. Front Cell Dev Biol 2022;10:875318. [DOI: 10.3389/fcell.2022.875318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Huang T, Bao H, Meng YH, Zhu JL, Chu XD, Chu XL, Pan JH. Tumour budding is a novel marker in breast cancer: the clinical application and future prospects. Ann Med 2022;54:1303-12. [PMID: 35535687 DOI: 10.1080/07853890.2022.2070272] [Reference Citation Analysis]
9 Kim Y, Kim D, Sung WJ, Hong J. High-Grade Endometrial Stromal Sarcoma: Molecular Alterations and Potential Immunotherapeutic Strategies. Front Immunol 2022;13:837004. [PMID: 35242139 DOI: 10.3389/fimmu.2022.837004] [Reference Citation Analysis]
10 Zhang Q, Li W. Correlation between amino acid metabolism and self-renewal of cancer stem cells: Perspectives in cancer therapy. World J Stem Cells 2022; 14(4): 267-286 [DOI: 10.4252/wjsc.v14.i4.267] [Reference Citation Analysis]
11 Jiang Y, Zhang Z, Wang X, Feng Z, Hong B, Yu D, Wang Y. A Novel Prognostic Factor TIPE2 in Bladder Cancer. Pathol Oncol Res 2022;28:1610282. [PMID: 35388275 DOI: 10.3389/pore.2022.1610282] [Reference Citation Analysis]
12 Wen F, Lu X, Huang W, Chen X, Ruan S, Gu S, Gu P, Li Y, Liu J, Liu S, Shu P. Characteristics of immunophenotypes and immunological in tumor microenvironment and analysis of immune implication of CXCR4 in gastric cancer. Sci Rep 2022;12:5720. [PMID: 35388021 DOI: 10.1038/s41598-022-08622-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xiang J, Shen Y, Zhang Y, Liu X, Zhou Q, Zhou Z, Tang J, Shao S, Shen Y. Multipotent Poly(Tertiary Amine-Oxide) Micelles for Efficient Cancer Drug Delivery. Adv Sci (Weinh) 2022;9:e2200173. [PMID: 35187868 DOI: 10.1002/advs.202200173] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
14 Jang JY, Sung B, Kim ND. Role of Induced Programmed Cell Death in the Chemopreventive Potential of Apigenin. Int J Mol Sci 2022;23:3757. [PMID: 35409117 DOI: 10.3390/ijms23073757] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
15 Wu J, Xiao Y, Lu W, Zhang Z, Yang H, Cui X, Wu D, Chen Y, Wang F. Correlation between Tumor Microenvironment and Immune Subtypes Based on CD8 T Cells Enhancing Personalized Therapy of Gastric Cancer. Journal of Oncology 2022;2022:1-23. [DOI: 10.1155/2022/8933167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Dalir Abdolahinia E, Barati G, Ranjbar-navazi Z, Kadkhoda J, Islami M, Hashemzadeh N, Maleki Dizaj S, Sharifi S. Application of nanogels as drug delivery systems in multicellular spheroid tumor model. Journal of Drug Delivery Science and Technology 2022;68:103109. [DOI: 10.1016/j.jddst.2022.103109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Cristi F, Gutiérrez T, Hitt MM, Shmulevitz M. Genetic Modifications That Expand Oncolytic Virus Potency. Front Mol Biosci 2022;9:831091. [DOI: 10.3389/fmolb.2022.831091] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Debom GN, Rubenich DS, Braganhol E. Adenosinergic Signaling as a Key Modulator of the Glioma Microenvironment and Reactive Astrocytes. Front Neurosci 2021;15:648476. [PMID: 35069091 DOI: 10.3389/fnins.2021.648476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mahhengam N, Kazemnezhad K, Setia Budi H, Ansari MJ, Olegovich Bokov D, Suksatan W, Thangavelu L, Siahmansouri H. Targeted therapy of tumor microenvironment by gold nanoparticles as a new therapeutic approach. Journal of Drug Targeting. [DOI: 10.1080/1061186x.2022.2032095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jacquemin V, Antoine M, Dom G, Detours V, Maenhaut C, Dumont JE. Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications. Cancers (Basel) 2022;14:280. [PMID: 35053446 DOI: 10.3390/cancers14020280] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Qiu X, Qu Y, Guo B, Zheng H, Meng F, Zhong Z. Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer. J Control Release 2021;341:498-510. [PMID: 34883139 DOI: 10.1016/j.jconrel.2021.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
22 Yang Y, Wang X, Qian H, Cheng L. Titanium-based sonosensitizers for sonodynamic cancer therapy. Applied Materials Today 2021;25:101215. [DOI: 10.1016/j.apmt.2021.101215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Galuszka A, Pawlicki P, Pardyak L, Chmurska-Gąsowska M, Pietsch-Fulbiszewska A, Duliban M, Turek W, Dubniewicz K, Ramisz G, Kotula-Balak M. Abundance of estrogen receptors involved in non-canonical signaling in the dog testis. Anim Reprod Sci 2021;235:106888. [PMID: 34839117 DOI: 10.1016/j.anireprosci.2021.106888] [Reference Citation Analysis]
24 Boliukh I, Rombel-Bryzek A, Żuk O, Radecka B. The role of heat shock proteins in neoplastic processes and the research on their importance in the diagnosis and treatment of cancer. Contemp Oncol (Pozn) 2021;25:73-9. [PMID: 34667432 DOI: 10.5114/wo.2021.106006] [Reference Citation Analysis]
25 Chen J, Wang Y, Zhang W, Zhao D, Zhang L, Zhang J, Fan J, Zhan Q. NOX5 mediates the crosstalk between tumor cells and cancer-associated fibroblasts via regulating cytokine network. Clin Transl Med 2021;11:e472. [PMID: 34459125 DOI: 10.1002/ctm2.472] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
26 Mo S, Pei Z, Dai L. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer. Genet Test Mol Biomarkers 2021;25:163-78. [PMID: 33734891 DOI: 10.1089/gtmb.2020.0141] [Reference Citation Analysis]
27 Thangam R, Patel KD, Kang H, Paulmurugan R. Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy-Current Status and Future Perspectives. Vaccines (Basel) 2021;9:935. [PMID: 34452059 DOI: 10.3390/vaccines9080935] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
28 González A, Alonso-González C, González-González A, Menéndez-Menéndez J, Cos S, Martínez-Campa C. Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments. Cancers (Basel) 2021;13:3263. [PMID: 34209857 DOI: 10.3390/cancers13133263] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 10.0] [Reference Citation Analysis]
29 Fontana F, Marzagalli M, Sommariva M, Gagliano N, Limonta P. In Vitro 3D Cultures to Model the Tumor Microenvironment. Cancers (Basel) 2021;13:2970. [PMID: 34199324 DOI: 10.3390/cancers13122970] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
30 Li X, Li Y, Yu Q, Qian P, Huang H, Lin Y. Metabolic reprogramming of myeloid-derived suppressor cells: An innovative approach confronting challenges. J Leukoc Biol 2021;110:257-70. [PMID: 34075637 DOI: 10.1002/JLB.1MR0421-597RR] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Ni Y, Zhou X, Yang J, Shi H, Li H, Zhao X, Ma X. The Role of Tumor-Stroma Interactions in Drug Resistance Within Tumor Microenvironment. Front Cell Dev Biol 2021;9:637675. [PMID: 34095111 DOI: 10.3389/fcell.2021.637675] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
32 Mortezaee K, Najafi M, Farhood B, Ahmadi A, Shabeeb D, Musa AE. Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization. Curr Cancer Drug Targets 2020;20:130-45. [PMID: 31738153 DOI: 10.2174/1568009619666191019143539] [Cited by in Crossref: 19] [Cited by in F6Publishing: 27] [Article Influence: 19.0] [Reference Citation Analysis]
33 Wang Q, Xiao M, Wang D, Hou X, Gao J, Liu J, Liu J. In Situ Supramolecular Self‐Assembly of Pt(IV) Prodrug to Conquer Cisplatin Resistance. Adv Funct Mater 2021;31:2101826. [DOI: 10.1002/adfm.202101826] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
34 Zhai M, Gong P, Li H, Peng J, Xu W, Song S, Liu X, Liu J, Liu J, Liu Z. Metastable interface biomimetic synthesis of a smart nanosystem for enhanced starvation/gas therapy. J Colloid Interface Sci 2021;599:149-57. [PMID: 33940438 DOI: 10.1016/j.jcis.2021.04.042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
35 Ollauri-Ibáñez C, Ayuso-Íñigo B, Pericacho M. Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization? Cancers (Basel) 2021;13:1552. [PMID: 33800564 DOI: 10.3390/cancers13071552] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Worrede A, Douglass SM, Weeraratna AT. The dark side of daylight: photoaging and the tumor microenvironment in melanoma progression. J Clin Invest 2021;131:143763. [PMID: 33720046 DOI: 10.1172/JCI143763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Delfi M, Sartorius R, Ashrafizadeh M, Sharifi E, Zhang Y, De Berardinis P, Zarrabi A, Varma RS, Tay FR, Smith BR, Makvandi P. Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy. Nano Today 2021;38:101119. [PMID: 34267794 DOI: 10.1016/j.nantod.2021.101119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 45] [Article Influence: 6.0] [Reference Citation Analysis]
38 Zhang H, Si J, Yue J, Ma S. The mechanisms and reversal strategies of tumor radioresistance in esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 2021;147:1275-86. [PMID: 33687564 DOI: 10.1007/s00432-020-03493-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
39 Du Y, Wang B, Jiang X, Cao J, Yu J, Wang Y, Wang X, Liu H. Identification and Validation of a Stromal EMT Related LncRNA Signature as a Potential Marker to Predict Bladder Cancer Outcome. Front Oncol 2021;11:620674. [PMID: 33747932 DOI: 10.3389/fonc.2021.620674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
40 Tripodi L, Vitale M, Cerullo V, Pastore L. Oncolytic Adenoviruses for Cancer Therapy. Int J Mol Sci 2021;22:2517. [PMID: 33802281 DOI: 10.3390/ijms22052517] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
41 Yan J, Meng W, Shan H, Zhang X, Zou L, Wang L, Shi J, Kong X. Melanin Nanoparticles Combined with CaO 2 Nanoparticles for Image-Guided Tumor Microenvironment-Responsive Multimodal Therapy. ACS Appl Nano Mater 2021;4:1351-63. [DOI: 10.1021/acsanm.0c02916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
42 Liu Y, Zou L, Wang P, Zhou J, Yuan C, Wang J. Construction of differential expression plasmids of NGF to detect its influence on PC12 cell neuronal differentiation. Exp Ther Med 2021;21:363. [PMID: 33732336 DOI: 10.3892/etm.2021.9794] [Reference Citation Analysis]
43 Wang X, Zhao X, He Z. Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy. Oncol Lett 2021;21:238. [PMID: 33664802 DOI: 10.3892/ol.2021.12499] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Giorello MB, Borzone FR, Labovsky V, Piccioni FV, Chasseing NA. Cancer-Associated Fibroblasts in the Breast Tumor Microenvironment. J Mammary Gland Biol Neoplasia 2021;26:135-55. [PMID: 33398516 DOI: 10.1007/s10911-020-09475-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
45 Han W, Meng F, Gan H, Guo F, Ke J, Wang L. Targeting self-assembled F127-peptide polymer with pH sensitivity for release of anticancer drugs. RSC Adv 2021;11:1461-71. [DOI: 10.1039/d0ra09898a] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Zhu S, Luo Z, Li X, Han X, Shi S, Zhang T. Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications. J Cancer 2021;12:54-64. [PMID: 33391402 DOI: 10.7150/jca.49692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
47 Gray M, Meehan J, Turnbull AK, Martínez-Pérez C, Kay C, Pang LY, Argyle DJ. The Importance of the Tumor Microenvironment and Hypoxia in Delivering a Precision Medicine Approach to Veterinary Oncology. Front Vet Sci 2020;7:598338. [PMID: 33282935 DOI: 10.3389/fvets.2020.598338] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Zhou C, Li C, Yan F, Zheng Y. Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma. Cancer Cell Int 2020;20:541. [PMID: 33292199 DOI: 10.1186/s12935-020-01560-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
49 Myers KV, Pienta KJ, Amend SR. Cancer Cells and M2 Macrophages: Cooperative Invasive Ecosystem Engineers. Cancer Control 2020;27:1073274820911058. [PMID: 32129079 DOI: 10.1177/1073274820911058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
50 Ashrafizadeh M, Bakhoda MR, Bahmanpour Z, Ilkhani K, Zarrabi A, Makvandi P, Khan H, Mazaheri S, Darvish M, Mirzaei H. Apigenin as Tumor Suppressor in Cancers: Biotherapeutic Activity, Nanodelivery, and Mechanisms With Emphasis on Pancreatic Cancer. Front Chem 2020;8:829. [PMID: 33195038 DOI: 10.3389/fchem.2020.00829] [Cited by in Crossref: 7] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
51 Qin S, Jiang J, Lu Y, Nice EC, Huang C, Zhang J, He W. Emerging role of tumor cell plasticity in modifying therapeutic response. Signal Transduct Target Ther 2020;5:228. [PMID: 33028808 DOI: 10.1038/s41392-020-00313-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
52 Hamada M, Yura Y. Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.Int J Mol Sci. 2020;21. [PMID: 32992948 DOI: 10.3390/ijms21197073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
53 Wang Q, Li XL, Mei Y, Ye JC, Fan W, Cheng GH, Zeng MS, Feng GK. The anti-inflammatory drug dimethyl itaconate protects against colitis-associated colorectal cancer. J Mol Med (Berl) 2020;98:1457-66. [PMID: 32840638 DOI: 10.1007/s00109-020-01963-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
54 Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 2020;10:12996. [PMID: 32747660 DOI: 10.1038/s41598-020-69787-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Wang C, Wang S, Wang Y, Wu H, Bao K, Sheng R, Li X. Microenvironment-triggered dual-activation of a photosensitizer- fluorophore conjugate for tumor specific imaging and photodynamic therapy. Sci Rep 2020;10:12127. [PMID: 32699340 DOI: 10.1038/s41598-020-68847-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Fujimura T, Aiba S. Significance of Immunosuppressive Cells as a Target for Immunotherapies in Melanoma and Non-Melanoma Skin Cancers. Biomolecules 2020;10:E1087. [PMID: 32707850 DOI: 10.3390/biom10081087] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
57 Mortezaee K. Immune escape: A critical hallmark in solid tumors. Life Sci 2020;258:118110. [PMID: 32698074 DOI: 10.1016/j.lfs.2020.118110] [Cited by in Crossref: 23] [Cited by in F6Publishing: 44] [Article Influence: 11.5] [Reference Citation Analysis]
58 Park C, Lee J, Son C, Lee N. A survey of herbal medicines as tumor microenvironment‐modulating agents. Phytotherapy Research 2021;35:78-94. [DOI: 10.1002/ptr.6784] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
59 Zhou X, Zhao W, Wang M, Zhang S, Li Y, Hu W, Ren L, Luo S, Chen Z. Dual-Modal Therapeutic Role of the Lactate Oxidase-Embedded Hierarchical Porous Zeolitic Imidazolate Framework as a Nanocatalyst for Effective Tumor Suppression. ACS Appl Mater Interfaces 2020;12:32278-88. [PMID: 32580547 DOI: 10.1021/acsami.0c05783] [Cited by in Crossref: 12] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
60 Vafaei S, Roudi R, Madjd Z, Aref AR, Ebrahimi M. Potential theranostics of circulating tumor cells and tumor-derived exosomes application in colorectal cancer. Cancer Cell Int 2020;20:288. [PMID: 32655320 DOI: 10.1186/s12935-020-01389-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
61 Wu Y, Yang D, Xu W, Song R, Li M, Wang Y, Zhou B, Wu N, Zhong W, Cai H, Tu J, Zhang D, Wu X. Tunable water-soluble carbon nitride by alkali-metal cations modification: Enhanced ROS-evolving and adsorption band for photodynamic therapy. Applied Catalysis B: Environmental 2020;269:118848. [DOI: 10.1016/j.apcatb.2020.118848] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
62 Zhu X, Xie X, Zhao Q, Zhang L, Li C, Zhao D. Potential Prognostic Value and Mechanism of Stromal-Immune Signature in Tumor Microenvironment for Stomach Adenocarcinoma. Biomed Res Int 2020;2020:4673153. [PMID: 32685487 DOI: 10.1155/2020/4673153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
63 Cheng YQ, Wang SB, Liu JH, Jin L, Liu Y, Li CY, Su YR, Liu YR, Sang X, Wan Q, Liu C, Yang L, Wang ZC. Modifying the tumour microenvironment and reverting tumour cells: New strategies for treating malignant tumours. Cell Prolif 2020;53:e12865. [PMID: 32588948 DOI: 10.1111/cpr.12865] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
64 Cao Y, Cao W, Qiu Y, Zhou Y, Guo Q, Gao Y, Lu N. Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis. Pharmacol Res 2020;159:104981. [PMID: 32492489 DOI: 10.1016/j.phrs.2020.104981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Ho YJ, Li JP, Fan CH, Liu HL, Yeh CK. Ultrasound in tumor immunotherapy: Current status and future developments. J Control Release 2020;323:12-23. [PMID: 32302759 DOI: 10.1016/j.jconrel.2020.04.023] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
66 Syed SN, Brüne B. MicroRNAs as Emerging Regulators of Signaling in the Tumor Microenvironment. Cancers (Basel) 2020;12:E911. [PMID: 32276464 DOI: 10.3390/cancers12040911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
67 Scala S, D'Alterio C, Milanesi S, Castagna A, Carriero R, Farina FM, Locati M, Borroni EM. New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM. Vaccines (Basel) 2020;8:E164. [PMID: 32260318 DOI: 10.3390/vaccines8020164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
68 Li ZL, Wang ZJ, Wei GH, Yang Y, Wang XW. Changes in extracellular matrix in different stages of colorectal cancer and their effects on proliferation of cancer cells. World J Gastrointest Oncol 2020; 12(3): 267-275 [PMID: 32206177 DOI: 10.4251/wjgo.v12.i3.267] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 13.0] [Reference Citation Analysis]
69 Mortezaee K. CXCL12/CXCR4 axis in the microenvironment of solid tumors: A critical mediator of metastasis. Life Sci 2020;249:117534. [PMID: 32156548 DOI: 10.1016/j.lfs.2020.117534] [Cited by in Crossref: 39] [Cited by in F6Publishing: 61] [Article Influence: 19.5] [Reference Citation Analysis]
70 Eguchi T, Taha EA, Calderwood SK, Ono K. A Novel Model of Cancer Drug Resistance: Oncosomal Release of Cytotoxic and Antibody-Based Drugs. Biology (Basel) 2020;9:E47. [PMID: 32150875 DOI: 10.3390/biology9030047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
71 Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med 2019;9:E84. [PMID: 31905724 DOI: 10.3390/jcm9010084] [Cited by in Crossref: 69] [Cited by in F6Publishing: 126] [Article Influence: 23.0] [Reference Citation Analysis]
72 Ylösmäki E, Cerullo V. Design and application of oncolytic viruses for cancer immunotherapy. Curr Opin Biotechnol 2020;65:25-36. [PMID: 31874424 DOI: 10.1016/j.copbio.2019.11.016] [Cited by in Crossref: 28] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
73 Syed SN, Frank AC, Raue R, Brüne B. MicroRNA-A Tumor Trojan Horse for Tumor-Associated Macrophages. Cells 2019;8:E1482. [PMID: 31766495 DOI: 10.3390/cells8121482] [Cited by in Crossref: 14] [Cited by in F6Publishing: 22] [Article Influence: 4.7] [Reference Citation Analysis]
74 Mortezaee K, Parwaie W, Motevaseli E, Mirtavoos-mahyari H, Musa AE, Shabeeb D, Esmaely F, Najafi M, Farhood B. Targets for improving tumor response to radiotherapy. International Immunopharmacology 2019;76:105847. [DOI: 10.1016/j.intimp.2019.105847] [Cited by in Crossref: 26] [Cited by in F6Publishing: 38] [Article Influence: 8.7] [Reference Citation Analysis]
75 Jahanafrooz Z, Mosafer J, Akbari M, Hashemzaei M, Mokhtarzadeh A, Baradaran B. Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment. J Cell Physiol 2020;235:4153-66. [PMID: 31647128 DOI: 10.1002/jcp.29337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
76 Wang P, Liang C, Zhu J, Yang N, Jiao A, Wang W, Song X, Dong X. Manganese-Based Nanoplatform As Metal Ion-Enhanced ROS Generator for Combined Chemodynamic/Photodynamic Therapy. ACS Appl Mater Interfaces 2019;11:41140-7. [PMID: 31603650 DOI: 10.1021/acsami.9b16617] [Cited by in Crossref: 26] [Cited by in F6Publishing: 43] [Article Influence: 8.7] [Reference Citation Analysis]
77 Mortezaee K, Potes Y, Mirtavoos-Mahyari H, Motevaseli E, Shabeeb D, Musa AE, Najafi M, Farhood B. Boosting immune system against cancer by melatonin: A mechanistic viewpoint. Life Sci 2019;238:116960. [PMID: 31629760 DOI: 10.1016/j.lfs.2019.116960] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 11.7] [Reference Citation Analysis]
78 Jiang Y, Zhan H. Communication between EMT and PD-L1 signaling: New insights into tumor immune evasion. Cancer Lett 2020;468:72-81. [PMID: 31605776 DOI: 10.1016/j.canlet.2019.10.013] [Cited by in Crossref: 59] [Cited by in F6Publishing: 96] [Article Influence: 19.7] [Reference Citation Analysis]
79 Taha EA, Ono K, Eguchi T. Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Int J Mol Sci 2019;20:E4588. [PMID: 31533245 DOI: 10.3390/ijms20184588] [Cited by in Crossref: 41] [Cited by in F6Publishing: 64] [Article Influence: 13.7] [Reference Citation Analysis]
80 Liao J, Jia Y, Wu Y, Shi K, Yang D, Li P, Qian Z. Physical‐, chemical‐, and biological‐responsive nanomedicine for cancer therapy. WIREs Nanomed Nanobiotechnol 2020;12. [DOI: 10.1002/wnan.1581] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
81 González-González A, García Nieto E, González A, Sánchez-Fernández C, Alonso-González C, Menéndez-Menéndez J, Gómez-Arozamena J, Cos S, Martínez-Campa C. Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts. Int J Mol Sci 2019;20:E3935. [PMID: 31412584 DOI: 10.3390/ijms20163935] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
82 Marchini A, Daeffler L, Pozdeev VI, Angelova A, Rommelaere J. Immune Conversion of Tumor Microenvironment by Oncolytic Viruses: The Protoparvovirus H-1PV Case Study.Front Immunol. 2019;10:1848. [PMID: 31440242 DOI: 10.3389/fimmu.2019.01848] [Cited by in Crossref: 26] [Cited by in F6Publishing: 34] [Article Influence: 8.7] [Reference Citation Analysis]
83 Burgos-Panadero R, Lucantoni F, Gamero-Sandemetrio E, Cruz-Merino L, Álvaro T, Noguera R. The tumour microenvironment as an integrated framework to understand cancer biology. Cancer Lett 2019;461:112-22. [PMID: 31325528 DOI: 10.1016/j.canlet.2019.07.010] [Cited by in Crossref: 23] [Cited by in F6Publishing: 34] [Article Influence: 7.7] [Reference Citation Analysis]
84 Peng D, Wang L, Li H, Cai C, Tan Y, Xu B, Le H. An immune infiltration signature to predict the overall survival of patients with colon cancer. IUBMB Life 2019;71:1760-70. [PMID: 31301220 DOI: 10.1002/iub.2124] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
85 Siewert B, Stuppner H. The photoactivity of natural products – An overlooked potential of phytomedicines? Phytomedicine 2019;60:152985. [DOI: 10.1016/j.phymed.2019.152985] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
86 Wang Y, Zhao W, Liu X, Guan G, Zhuang M. ARL3 is downregulated and acts as a prognostic biomarker in glioma. J Transl Med 2019;17:210. [PMID: 31234870 DOI: 10.1186/s12967-019-1914-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
87 Bretscher C, Marchini A. H-1 Parvovirus as a Cancer-Killing Agent: Past, Present, and Future. Viruses 2019;11:E562. [PMID: 31216641 DOI: 10.3390/v11060562] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
88 Marei HE, Althani A, Caceci T, Arriga R, Sconocchia T, Ottaviani A, Lanzilli G, Roselli M, Caratelli S, Cenciarelli C, Sconocchia G. Recent perspective on CAR and Fcγ-CR T cell immunotherapy for cancers: Preclinical evidence versus clinical outcomes. Biochem Pharmacol 2019;166:335-46. [PMID: 31176617 DOI: 10.1016/j.bcp.2019.06.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
89 Luo L, Lv M, Zhuang X, Zhang Q, Qiao T. Irradiation increases the immunogenicity of lung cancer cells and irradiation-based tumor cell vaccine elicits tumor-specific T cell responses in vivo. Onco Targets Ther 2019;12:3805-15. [PMID: 31190880 DOI: 10.2147/OTT.S197516] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
90 Vidoni C, Ferraresi A, Secomandi E, Vallino L, Dhanasekaran DN, Isidoro C. Epigenetic targeting of autophagy for cancer prevention and treatment by natural compounds. Semin Cancer Biol 2020;66:34-44. [PMID: 31054926 DOI: 10.1016/j.semcancer.2019.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
91 Jonckheere N, Van Seuningen I. Fine-tuning autophagy in pancreatic adenocarcinoma: full blockage is required. Ann Transl Med 2019;7:S43. [PMID: 31032322 DOI: 10.21037/atm.2019.03.01] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
92 Huet E, Jaroz C, Nguyen HQ, Belkacemi Y, de la Taille A, Stavrinides V, Whitaker H. Stroma in normal and cancer wound healing. FEBS J 2019;286:2909-20. [PMID: 30958920 DOI: 10.1111/febs.14842] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
93 Qu Y, Dou B, Tan H, Feng Y, Wang N, Wang D. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment. Mol Cancer 2019;18:69. [PMID: 30927928 DOI: 10.1186/s12943-019-0992-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 45] [Article Influence: 11.3] [Reference Citation Analysis]
94 Ferioli M, Zauli G, Maiorano P, Milani D, Mirandola P, Neri LM. Role of physical exercise in the regulation of epigenetic mechanisms in inflammation, cancer, neurodegenerative diseases, and aging process. J Cell Physiol 2019. [PMID: 30767204 DOI: 10.1002/jcp.28304] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 7.7] [Reference Citation Analysis]
95 Ahmadi A, Najafi M, Farhood B, Mortezaee K. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy. J Cell Physiol 2019;234:12173-87. [PMID: 30537043 DOI: 10.1002/jcp.27955] [Cited by in Crossref: 56] [Cited by in F6Publishing: 76] [Article Influence: 14.0] [Reference Citation Analysis]